Newer biologic and small-molecule therapies for inflammatory bowel disease

DC Baumgart, C Le Berre - New England Journal of Medicine, 2021 - Mass Medical Soc
Newer Biologic and Small-Molecule Therapies for IBD There is still no cure for inflammatory
bowel disease. This review covers newer treatments that reflect our understanding of the …

[HTML][HTML] Human gut-associated lymphoid tissues (GALT); diversity, structure, and function

UM Mörbe, PB Jørgensen, TM Fenton, N von Burg… - Mucosal …, 2021 - Elsevier
Gut-associated lymphoid tissues (GALT) are the key antigen sampling and adaptive immune
inductive sites within the intestinal wall. Human GALT includes the multi-follicular Peyer's …

Targeting immune cell circuits and trafficking in inflammatory bowel disease

MF Neurath - Nature immunology, 2019 - nature.com
Inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis are
characterized by uncontrolled activation of intestinal immune cells in a genetically …

COVID-19 and immunomodulation in IBD

MF Neurath - Gut, 2020 - gut.bmj.com
The current coronavirus pandemic is an ongoing global health crisis due to COVID-19,
caused by severe acute respiratory syndrome coronavirus 2. Although COVID-19 leads to …

Management of patients with Crohn's disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting

DT Rubin, MT Abreu, V Rai, CA Siegel, V Ahuja… - …, 2020 - gastrojournal.org
The 2020 annual meeting for IOIBD was scheduled to occur in March, but was cancelled
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …

Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation

S Zundler, C Günther, AE Kremer, MM Zaiss… - Nature Reviews …, 2023 - nature.com
Immune cell trafficking is a complex and tightly regulated process that is indispensable for
the body's fight against pathogens. However, it is also increasingly acknowledged that …

Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances

S Zundler, E Becker, LL Schulze, MF Neurath - Gut, 2019 - gut.bmj.com
Intestinal immune cell trafficking has been identified as a central event in the pathogenesis
of inflammatory bowel diseases (IBD). Intensive research on different aspects of the immune …

Human intestinal B cells in inflammatory diseases

J Spencer, M Bemark - Nature reviews Gastroenterology & hepatology, 2023 - nature.com
The intestinal lumen contains an abundance of bacteria, viruses and fungi alongside
ingested material that shape the chronically active intestinal immune system from early life to …

How do we predict a patient's disease course and whether they will respond to specific treatments?

B Verstockt, M Parkes, JC Lee - Gastroenterology, 2022 - Elsevier
Gastroenterologists will be all too familiar with the difficult decisions that managing
inflammatory bowel disease often presents. How aggressively should I treat this patient? Do …

Targeting B cells for inflammatory bowel disease treatment: back to the future

T Castro-Dopico, JF Colombel, S Mehandru - Current opinion in …, 2020 - Elsevier
B cells are critical to immune homeostasis at mucosal surfaces including those of the
gastrointestinal tract. B cell-related abnormalities, comprising of a lympho-plasmacytic …